Alector, Inc. (ALEC)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.51
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.09
P/B Ratio
16.08
Institutional Ownership
74.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 10.00M | $21.0M | 9.01% | -- | 2026-03-31 |
| BlackRock, Inc. | 7.74M | $16.0M | 6.97% | +593.5K | 2026-03-31 |
| Foresite Capital Management IV, LLC | 3.89M | $8.0M | 3.50% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.68M | $7.0M | 3.31% | -- | 2026-03-31 |
| Merck & Co., Inc. | 3.55M | $7.0M | 3.19% | -- | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 3.33M | $7.0M | 3.00% | +967.7K | 2026-03-31 |
| 683 Capital Management, LLC | 3.20M | $6.0M | 2.88% | -150.0K | 2026-03-31 |
| Balyasny Asset Management L.P. | 2.94M | $6.0M | 2.64% | -330.3K | 2026-03-31 |
| Nantahala Capital Management, LLC | 2.82M | $6.0M | 2.54% | -- | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.58M | $5.0M | 2.33% | -- | 2026-03-31 |